Skip to main content

RotaTeq Side Effects

Generic name: rotavirus vaccine

Medically reviewed by Last updated on Feb 7, 2024.

Note: This document contains side effect information about rotavirus vaccine. Some dosage forms listed on this page may not apply to the brand name RotaTeq.

Applies to rotavirus vaccine: oral powder for suspension, oral suspension. Other dosage forms:

Serious side effects of RotaTeq

Along with its needed effects, rotavirus vaccine (the active ingredient contained in RotaTeq) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking rotavirus vaccine:

More common

Less common


Incidence not known

Other side effects of RotaTeq

Some side effects of rotavirus vaccine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to rotavirus vaccine: oral liquid, oral powder for reconstitution, oral suspension.


The most common adverse events were irritability, cough, runny nose, fever, loss of appetite, diarrhea, and vomiting.[Ref]


Very common (10% or more): Diarrhea (24.1%), vomiting (15.2%)

Common (1% to 10%): Flatulence, abdominal pain

Uncommon (0.1% to 1%): Hematochezia, gastroenteritis

Rare (less than 0.1%): Intussusception, frequent bowel movement

Postmarketing reports: Recurrent intussusception (including death), gastroenteritis with vaccine viral shedding in infants with Severe Combined Immunodeficiency Disease (SCID)[Ref]


Very common (10% or more): Fever (28%), otitis media (14.5%)

Uncommon (0.1% to 1%): Death

Postmarketing reports: Maladministration, transmission of vaccine virus strains from vaccine recipient to non-vaccinated contacts[Ref]


Very common (10% or more): Cough/runny nose (31%)

Common (1% to 10%): Nasopharyngitis, bronchospasm

Uncommon (0.1% to 1%): Bronchiolitis, pneumonia

Rare (less than 0.1%): Apnea

Postmarketing reports: Apnea in very premature infants (28 weeks gestation or less)[Ref]


Very common (10% or more): Fussiness/irritability (52%)[Ref]


Uncommon (0.1% to 1%): Dermatitis

Rare (less than 0.1%): Urticaria, rash, eczema, dermatitis atopic

Postmarketing reports: Angioedema[Ref]


Very common (10% or more): Loss of appetite (25%)

Uncommon (0.1% to 1%): Gastroenteritis

Rare (less than 0.1%): Dehydration, weight gain poor[Ref]


Postmarketing reports: Anaphylactic reaction[Ref]

Nervous system

Rare (less than 0.1%): Seizure, hypotonic-hyporesponsive episode, syncope-vasovagal[Ref]


Rare (less than 0.1%): Kawasaki disease[Ref]


Postmarketing reports: Idiopathic thrombocytopenic purpura[Ref]


Uncommon (0.1% to 1%): Urinary tract infection[Ref]


1. (2006) "Product Information. RotaTeq (rotavirus vaccine)." Merck & Co., Inc

2. Cerner Multum, Inc. "Australian Product Information."

3. (2008) "Product Information. Rotarix (rotavirus vaccine)." GlaxoSmithKline

4. Cerner Multum, Inc. "UK Summary of Product Characteristics."

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.